Pommey S - Search Results

1

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.

Buisseret L, Pommey S, Allard B, Garaud S, Bergeron M, Cousineau I, Ameye L, Bareche Y, Paesmans M, Crown JPA, Di Leo A, Loi S, Piccart-Gebhart M, Willard-Gallo K, Sotiriou C, Stagg J. Buisseret L, et al. Among authors: pommey s. Ann Oncol. 2018 Apr 1;29(4):1056-1062. doi: 10.1093/annonc/mdx730. Ann Oncol. 2018. PMID: 29145561 Free PMC article. Clinical Trial.

2

Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell.

Stagg J, Pommey S, Eliopoulos N, Galipeau J. Stagg J, et al. Among authors: pommey s. Blood. 2006 Mar 15;107(6):2570-7. doi: 10.1182/blood-2005-07-2793. Epub 2005 Nov 17. Blood. 2006. PMID: 16293599 Free article.

3

Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response.

Stagg J, Sharkey J, Pommey S, Young R, Takeda K, Yagita H, Johnstone RW, Smyth MJ. Stagg J, et al. Among authors: pommey s. Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16254-9. doi: 10.1073/pnas.0806849105. Epub 2008 Oct 6. Proc Natl Acad Sci U S A. 2008. PMID: 18838682 Free PMC article.

4

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.

Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, Dwyer KM, Smyth MJ. Stagg J, et al. Among authors: pommey s. Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1547-52. doi: 10.1073/pnas.0908801107. Epub 2010 Jan 4. Proc Natl Acad Sci U S A. 2010. PMID: 20080644 Free PMC article.

5

Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells.

Pommey S, Lu B, McRae J, Stagg J, Hill P, Salvaris E, Robson SC, d'Apice AJ, Cowan PJ, Dwyer KM. Pommey S, et al. Hepatology. 2013 Apr;57(4):1597-606. doi: 10.1002/hep.25985. Epub 2013 Mar 14. Hepatology. 2013. PMID: 22829222

6

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer.

Loi S, Pommey S, Haibe-Kains B, Beavis PA, Darcy PK, Smyth MJ, Stagg J. Loi S, et al. Among authors: pommey s. Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11091-6. doi: 10.1073/pnas.1222251110. Epub 2013 Jun 17. Proc Natl Acad Sci U S A. 2013. PMID: 23776241 Free PMC article.

7

Anti-CD73 therapy impairs tumor angiogenesis.

Allard B, Turcotte M, Spring K, Pommey S, Royal I, Stagg J. Allard B, et al. Among authors: pommey s. Int J Cancer. 2014 Mar 15;134(6):1466-73. doi: 10.1002/ijc.28456. Epub 2013 Sep 18. Int J Cancer. 2014. PMID: 23982901

8

Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.

Allard B, Pommey S, Smyth MJ, Stagg J. Allard B, et al. Among authors: pommey s. Clin Cancer Res. 2013 Oct 15;19(20):5626-35. doi: 10.1158/1078-0432.CCR-13-0545. Epub 2013 Aug 27. Clin Cancer Res. 2013. PMID: 23983257

9

The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis.

Spring K, Fournier P, Lapointe L, Chabot C, Roussy J, Pommey S, Stagg J, Royal I. Spring K, et al. Among authors: pommey s. Oncogene. 2015 Oct 29;34(44):5536-47. doi: 10.1038/onc.2015.9. Epub 2015 Mar 16. Oncogene. 2015. PMID: 25772245

10

CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer.

Leclerc BG, Charlebois R, Chouinard G, Allard B, Pommey S, Saad F, Stagg J. Leclerc BG, et al. Among authors: pommey s. Clin Cancer Res. 2016 Jan 1;22(1):158-66. doi: 10.1158/1078-0432.CCR-15-1181. Epub 2015 Aug 7. Clin Cancer Res. 2016. PMID: 26253870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters